LXEO vs PEP · $147.7M cap vs P/E 22, rev $43.62B
Lexeo Therapeutics, Inc. Common Stock (LXEO) versus PepsiCo Inc (PEP) — a side-by-side from cached financials, not a winner call.
Lexeo Therapeutics, Inc. Common Stock (LXEO) is a biotechnology company listed on US.
PepsiCo Inc (PEP) is a beverages - non-alcoholic company listed on NASDAQ. It is led by Ramon Luis Laguarta.
LXEO does not have a complete income-statement cache yet.
Latest reported PEP revenue for 2026-06-13 was $43.62B. Net income was $5.31B. PEP currently screens at market cap $193.55B and trailing P/E 22.2.
LXEO currently screens at market cap $147.7M. PEP currently screens at market cap $193.55B and trailing P/E 22.2.
Not investment advice. Open the LXEO and PEP stock pages for the full models.
Not investment advice.